These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


304 related items for PubMed ID: 6230447

  • 1. Cells with immunoregulatory function: the human macrophages and the effects of remittive drugs.
    Harth M, Keown PA, Orange J.
    J Rheumatol Suppl; 1983 Dec; 11():76-80. PubMed ID: 6230447
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Auranofin and aurothiomalate sodium: a comparative review (and II) Efficacy, tolerance and safety].
    Batlle Gualda E.
    Med Clin (Barc); 1985 Jun 08; 85(2):73-9. PubMed ID: 3160899
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effects of auranofin and gold sodium aurothiomalate on the chemiluminescent response of stimulated synovial tissue cells from patients with rheumatoid arthritis.
    Harth M, McCain GA, Orange JF.
    J Rheumatol; 1985 Oct 08; 12(5):881-4. PubMed ID: 3936929
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment with auranofin in patients with rheumatoid arthritis, previously experiencing drug related side effects to sodium aurothiomalate.
    Davis P, Landon M.
    J Rheumatol; 1985 Jun 08; 12(3):622. PubMed ID: 3930724
    [No Abstract] [Full Text] [Related]

  • 11. A double-blind study comparing sodium aurothiomalate and auranofin in patients with rheumatoid arthritis previously stabilized on sodium aurothiomalate.
    Hull RG, Morgan SH, Parke AL, Childs L, Goldman M, Hughes GR.
    Int J Clin Pharmacol Res; 1984 Jun 08; 4(6):395-401. PubMed ID: 6442711
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
    Chamouard JM, Clerc D, Bisson M, Medicis P, Massias P.
    Rev Rhum Mal Osteoartic; 1985 Apr 08; 52(4):277-82. PubMed ID: 3923604
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Auranofin.
    Davis P.
    Clin Rheum Dis; 1984 Aug 08; 10(2):369-83. PubMed ID: 6239742
    [Abstract] [Full Text] [Related]

  • 17. Changes in mononuclear cell function in patients with rheumatoid arthritis following treatment with auranofin.
    Coughlan RJ, Richter MB, Panayi GS.
    Clin Rheumatol; 1984 Mar 08; 3 Suppl 1():25-32. PubMed ID: 6432410
    [Abstract] [Full Text] [Related]

  • 18. Effects of auranofin on the radiological progression of joint erosion in rheumatoid arthritis.
    Gofton JP, O'Brien WM.
    J Rheumatol Suppl; 1982 Mar 08; 8():169-72. PubMed ID: 6813480
    [No Abstract] [Full Text] [Related]

  • 19. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
    Leonard PA, Bienz SR, Clegg DO, Ward JR.
    J Rheumatol; 1987 Feb 08; 14(1):55-9. PubMed ID: 3106632
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.